Chemomab Therapeutics files updated corporate presentation for October 2021

Chemomab Therapeutics Ltd.

Filed an updated corporate presentation covering its fibrotic disease pipeline.
Presentation date is October 2021; no specific financial or clinical data disclosed in the filing.
Presentation is furnished under Item 7.01 Regulation FD, not incorporated by reference.
No material changes to previously disclosed information are evident from the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.